COVID-19 vaccine effectiveness against severe omicron-related outcomes in children aged 5 to 11 years in Ontario: A Canadian immunization research network (CIRN) study.
Saved in:
| Title: | COVID-19 vaccine effectiveness against severe omicron-related outcomes in children aged 5 to 11 years in Ontario: A Canadian immunization research network (CIRN) study. |
|---|---|
| Authors: | Piché-Renaud PP; Division of Pediatric Infectious Diseases, The Hospital for Sick Children, Toronto, ON, Canada; Department of Pediatrics, University of Toronto, Toronto, ON, Canada; Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Canada; Institute for Health, Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada; Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, ON, Canada; ICES, Toronto, ON, Canada. Electronic address: pp.piche-renaud@sickkids.ca., Drover SSM; ICES, Toronto, ON, Canada., Austin PC; Institute for Health, Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada; ICES, Toronto, ON, Canada., Morris SK; Division of Pediatric Infectious Diseases, The Hospital for Sick Children, Toronto, ON, Canada; Department of Pediatrics, University of Toronto, Toronto, ON, Canada; Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Canada; Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, ON, Canada., Buchan SA; Institute for Health, Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada; Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, ON, Canada; ICES, Toronto, ON, Canada; Public Health Ontario, Toronto, ON, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada., Nasreen S; School of Public Health, SUNY Downstate Health Sciencest Unviersity, Brooklyn, NY, USA., Schwartz KL; ICES, Toronto, ON, Canada; Public Health Ontario, Toronto, ON, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada., Tadrous M; Institute for Health, Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada; ICES, Toronto, ON, Canada; Women's College Hospital, Toronto, ON, Canada., Thampi N; Public Health Ontario, Toronto, ON, Canada; Department of Pediatrics, University of Ottawa, Ottawa, ON, Canada., Wilson SE; Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, ON, Canada; ICES, Toronto, ON, Canada; Public Health Ontario, Toronto, ON, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada., Wilson K; Department of Medicine, University of Ottawa, Ottawa, ON, Canada; Bruyere Hospital Research Institutes, Ottawa, ON, Canada., Guttmann A; Department of Pediatrics, University of Toronto, Toronto, ON, Canada; Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Canada; Institute for Health, Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada; ICES, Toronto, ON, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada., Kwong JC; Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, ON, Canada; ICES, Toronto, ON, Canada; Public Health Ontario, Toronto, ON, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada; Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada; University Health Network, Toronto, ON, Canada. |
| Source: | Vaccine [Vaccine] 2025 Jan 12; Vol. 44, pp. 126539. Date of Electronic Publication: 2024 Nov 30. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
